Germing U - Search Results

1

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.

Broseus J, Florensa L, Zipperer E, Schnittger S, Malcovati L, Richebourg S, Lippert E, Cermak J, Evans J, Mounier M, Raya JM, Bailly F, Gattermann N, Haferlach T, Garand R, Allou K, Besses C, Germing U, Haferlach C, Travaglino E, Luno E, Pinan MA, Arenillas L, Rozman M, Perez Sirvent ML, Favre B, Guy J, Alonso E, Ahwij N, Jerez A, Hermouet S, Maynadié M, Cazzola M, Girodon F. Broseus J, et al. Among authors: germing u. Haematologica. 2012 Jul;97(7):1036-41. doi: 10.3324/haematol.2011.053918. Epub 2012 Apr 24. Haematologica. 2012. PMID: 22532522 Free PMC article.

2

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Aul C, Gattermann N, Germing U, Runde V, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1992 Aug 14;117(33):1223-31. doi: 10.1055/s-2008-1062434. Dtsch Med Wochenschr. 1992. PMID: 1499520 German.

3

[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].

Aul C, Germing U, Gattermann N, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1996 Sep 13;121(37):1113-8. doi: 10.1055/s-2008-1043114. Dtsch Med Wochenschr. 1996. PMID: 8925725 German.

4

Problems in the classification of CMML--dysplastic versus proliferative type.

Germing U, Gattermann N, Minning H, Heyll A, Aul C. Germing U, et al. Leuk Res. 1998 Oct;22(10):871-8. doi: 10.1016/s0145-2126(97)00192-6. Leuk Res. 1998. PMID: 9766745

5

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients.

Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Germing U, et al. Leuk Res. 2000 Dec;24(12):983-92. doi: 10.1016/s0145-2126(00)00088-6. Leuk Res. 2000. PMID: 11077111

6

Refractory anemia with excess of blasts in transformation: a dying category?

Germing U, Gattermann N. Germing U, et al. Leuk Res. 2001 Dec;25(12):1095-6. doi: 10.1016/s0145-2126(01)00080-7. Leuk Res. 2001. PMID: 11684282 No abstract available.

7

New prognostic parameters for chronic myelomonocytic leukemia.

Germing U, Strupp C, Aivado M, Gattermann N. Germing U, et al. Blood. 2002 Jul 15;100(2):731-2; author reply 732-3. doi: 10.1182/blood-2002-01-0330. Blood. 2002. PMID: 12123232 Free article. No abstract available.

8

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.

Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U. Strupp C, et al. Among authors: germing u. Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5. Leuk Res. 2003. PMID: 12620291

9

No increase in age-specific incidence of myelodysplastic syndromes.

Germing U, Strupp C, Kündgen A, Bowen D, Aul C, Haas R, Gattermann N. Germing U, et al. Haematologica. 2004 Aug;89(8):905-10. Haematologica. 2004. PMID: 15339672

10

Risk assessment in chronic myelomonocytic leukemia (CMML).

Germing U, Kündgen A, Gattermann N. Germing U, et al. Leuk Lymphoma. 2004 Jul;45(7):1311-8. doi: 10.1080/1042819042000207271. Leuk Lymphoma. 2004. PMID: 15359628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page